ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,858Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 534

$722K Total Retail Price of All Prescriptions

Rank: 18 out of 534

334 Patients Receiving at Least One Drug in Part D
11%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Massachusetts
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 334 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

4% of this provider’s 334 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

5% of this provider’s 754 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$105 was the average price of a prescription from this provider, compared to $110 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Massachusetts
CLOZAPINE 419 0 1 8
TRAZODONE HCL 387 75 2 1
QUETIAPINE FUMARATE 337 13 3 5
LAMOTRIGINE 274 37 4 6
BENZTROPINE MESYLATE 249 16 R 5 12
SUBOXONE 249 0 5 20
RISPERIDONE 212 44 7 2
LITHIUM CARBONATE 204 19 8 16
ABILIFY 199 0 9 9
CITALOPRAM HBR 192 38 10 3
CLONIDINE HCL 187 0 11 24
SERTRALINE HCL 179 31 12 7
FLUOXETINE HCL 173 32 13 4
OLANZAPINE 167 42 14 11
DIVALPROEX SODIUM ER 163 15 15 23
BUPROPION HCL SR 160 19 16 10
GABAPENTIN 160 0 16 17
SEROQUEL 140 18 18 25
HALOPERIDOL 126 12 19 28
ZOLPIDEM TARTRATE 123 13 20 13
FLUPHENAZINE HCL 114 45 21 48
RISPERDAL CONSTA 109 0 22 38
OXCARBAZEPINE 94 0 23 27
VENLAFAXINE HCL ER 87 0 24 15
MIRTAZAPINE 87 0 24 14
SEROQUEL XR 85 0 26 32
PRAZOSIN HCL 82 0 27 50
HYDROXYZINE PAMOATE 81 0 R 28 39
CYMBALTA 74 0 29 19
BUPRENORPHINE HCL 69 0 S3 30 68
ESCITALOPRAM OXALATE 64 27 31 36
CARBAMAZEPINE 61 0 32 43
CLOMIPRAMINE HCL 60 0 R 33 61
DIVALPROEX SODIUM 60 0 33 18
BUSPIRONE HCL 59 0 35 22
ZIPRASIDONE HCL 56 0 36 35
PAROXETINE HCL 55 0 37 21
PROPRANOLOL HCL 54 0 38 34
CYPROHEPTADINE HCL 50 0 R 39 82
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.